For over 80 years, CH2 has been dedicated to our fundamental purpose - Enabling Australian Healthcare. The name CH2 comes from our strong Australian heritage and the collaboration of two uniquely Australian companies – the Victorian Hospitals Association (later Hospital Supplier of Australia or HSA), and Clifford Hallam Pharmaceuticals. Clifford Hallam Pharmaceuticals was formed in 1978 by Chevel Coonan and Clifford Rex Skiller. Clifford's business associate owned the Hallam Chemist in York St Sydney. With a joint vision of providing excellence in the Australian healthcare supply industry, tapping into expert local knowledge, HSA and Clifford Hallam Healthcare merged in 2006 to become the CH2 we know today.
1918 - 1978 1918 - Formation of the Country Hospital Association (’CHA’) 1920 - Formation of the Metropolitan Hospitals Association (’MHA’) 1938 - Registration of the Victorian Hospitals Association (’VHA’) with equal number of CHA & VHA members appointed to board 1974 - Amalgamation of the VHA, MHA and CHA 1978 - Formation of Clifford Hallam Pharmaceuticals (’CHP’) by Chevel Coonan and Clifford Skiller
1979 - 2001 1997 - Spotless acquires CHP 1998 - VHA changes its name to the Victorian Healthcare Association. In the same year, Hospital Supplies Australia ('HSA') is established 2001 - Acquisition of HSA by API
2005 - 2014 2005 - API forms a joint venture with ABN AMRO to acquire HSA and CHP, renaming the combined business - 'Clifford Hallam Healthcare' 2008 - CH2 acquires Cottman Australia. Allegro Funds takes over management of ABN AMRO’s portfolio 2009 - RHC and CH2 partner on the supply and distribution of pharmaceuticals & medical consumables 2010 - CH2 acquires Intouch Direct to expand offering into the growing Aged Care & Community sector 2014 - CH2 acquires Elders Vet Suppliers to strengthen its offering into the Veterinary sector 2014 - RHC and CH2 renew their partnership
2015 - 2020 2015 - Long term shareholders David Collins and Peter Lacaze increase their ownership to 100% of the business. 2016 - CH2 acquires TCS to expand the growing Private Label Business 2017 - Granted CSO Distribution. 2018 - Full Line Supply Retail Pharmacy 2020 – CH2 divests the Animal Health portfolio to ensure 100% focus on human health
2021 - Now 2021 - CH2 opens the Townsville site to service North Queensland 2022 - Commencement of new Adelaide site 2023 - CH2 acquires the CHS Hospital business, adding scale to the CH2 Hospital Pharmacy business 2024 - Acquisition of Oborne Health Supplies - Feb 2024 to launch the Complementary Medicines Business Unit 2024 - A transformative merger between ParagonCare and CH2 creating a leading healthcare wholesaler, distributor and manufacturer